Table 1 Demographic and clinical characteristics of the study participants, southwest Ethiopia, 2010
Characteristics | Frequency(percentage) |
|---|---|
Gender | Â |
 Male | 221(51.9) |
 Female | 205(48.1) |
Mothers attended ANC | Â |
 Yes | 254(59.6) |
 No | 114(26.8) |
 Not available | 58(13.6) |
Maternal CD4 count during ANC | Â |
 <200 | 46(10.8) |
 200-350 | 74(17.4) |
 >350 | 124(29.1) |
 Not done | 2(0.5) |
 Not available | 180(42.3) |
Maternal clinical stage during ANC | Â |
 WHO stage I | 171(40.1) |
 WHO stage II | 46(10.8) |
 WHO stage III | 27(6.3) |
 WHO stage IV | 2(0.5) |
 Not available | 180(42.3) |
Type of PMTCT prophylaxis received by the mother during ANC | Â |
 Combined ARV prophylaxis | 76(17.8) |
 ART | 104(24.4) |
 Not documented | 12(2.8) |
 None | 234(54.9) |
Mother’s place of delivery |  |
 Home | 137(32.2) |
 Health facility | 250(58.7) |
 Not available | 39(9.2) |
 Mode of delivery |  |
 Caesarian section | 10(2.3) |
 Spontaneous vaginal delivery | 362(85.0) |
 Not documented | 54(12.7) |
Mothers took intra partum ARV prophylaxis | Â |
 Yes | 247(58.0) |
 No | 146(34.3) |
 Not documented | 33(7.7) |
Types of ARV received by mother during labor | Â |
 Single-dose NVP | 68(16.0) |
 Combined ARV prophylaxis | 77(18.1) |
 HAART | 104(24.4) |
 None | 145(34.0) |
 Not documented | 32(7.5) |
Type of infant PMTCT interventions | Â |
 Single-dose NVP | 89(20.9) |
 Single-dose NVP + AZT | 135(31.7) |
 Not documented | 39(9.2) |
 None | 163(38.3) |
Infant feeding option chosen | Â |
 Exclusive replacement feeding(ERF) | 23(5.4) |
 Exclusive breastfeeding (EBF) | 342(80.3) |
 Not available | 61(14.3) |
Father’s HIV status |  |
 Positive | 188(44.1) |
 Negative | 41(9.6) |
 Not tested | 182(42.7) |
 Separated | 15(3.5) |
DNA PCR result of the infant | Â |
 Not done | 65(15.3) |
 Negative | 318(74.6) |
 Positive | 31(7.3) |
 indeterminate pending | 12(2.8) |
Infant feeding practice | Â |
 Infant on exclusive breast feeding | 99(23.2) |
 Infant is on exclusive replacement feeding | 24(5.6) |
 Infant is on mixed feeding | 22(5.2) |
 Infant is on complementary feeding | 48(11.3) |
 Infant is weaned off | 193(45.3) |
 Not documented | 40(9.4) |
Age at which complementary feeding is started | Â |
 Before 4 months | 19(4.5) |
 4-6 months | 88(20.7) |
 After 6 months | 115(27.0) |
 Not documented | 204(47.9) |
Duration of breast feeding | Â |
 <6 months | 9(2.1) |
 6-12 months | 134(31.5) |
 12-18 months | 41(9.6) |
 >18 months | 11(2.6) |
 Not documented | 231(54.2) |
Maternal clinical stage during breast feeding | Â |
 WHO stage I | 210(49.3) |
 WHO stage II | 78(18.3) |
 WHO stage III | 32(7.5) |
 WHO stage IV | 6(1.4) |
 Not documented | 100(23.5) |
Maternal status during breast feeding | Â |
 On Pre ART | 240(56.3) |
 On ART | 102(23.9) |
 Not enrolled/Unknown | 61(14.3) |
 Not applicable | 23(5.4) |
Maternal adherence to ART | Â |
 Good | 92(21.6) |
 Fair | 2(0.5) |
 Poor | 3(0.7) |
 Mother on Pre ART | 238(55.9) |
 Not applicable | 91(21.4) |
Maternal CD4 count during breastfeeding | Â |
 <200 | 35(8.2) |
 200-350 | 84(19.7) |
 >350 | 196(46.0) |
 Not documented | 111(26.0) |
Developmental pattern of the child | Â |
 Appropriate | 343(80.5) |
 Delayed | 40(9.4) |
 Not documented | 43(10.1) |
Growth pattern of the child | Â |
 Normal | 315(73.9) |
 Abnormal | 68(16.0) |
 Not documented | 43(10.1) |
Final infection status of the infant | Â |
 Infected | 41(9.6) |
 Not infected | 385(90.4) |
Infant outcomes | Â |
 Discharged | 171(40.1) |
 Lost | 168(39.4) |
 Dead | 6(1.4) |
 On HAART | 26(6.1) |
 Still on follow up | 47(11.0) |
 Transfer out | 8(1.9) |
Age at discharge from the programme | Â |
 <1 year | 86(20.2) |
 12-18 months | 73(17.1) |
 18 months | 7(1.6) |
 >18 months | 5(1.2) |
 Not documented | 255(59.9) |